Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Fat tissue extract may help treat vitiligo by reducing cell stress and promoting skin repair.

Human skin's melanocytes respond to light by changing shape, producing pigments and hormones, which may affect sleep patterns.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Ammonium bisulfite in hair bleach can cause facial eczema.

Combining FCS and MPG is more effective for treating stable vitiligo than using either alone.

Correcting trace element imbalances may help reduce alopecia areata symptoms.

Alopecia areata may be influenced by both genetics and environment, requiring family monitoring and addressing stress and infections.

Alopecia is increasing globally, and homeopathy combined with lifestyle changes may help manage it effectively.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

The patient's hair loss is most likely due to diffuse alopecia areata.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Platelet-rich plasma may improve vitiligo treatment when used with phototherapy.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

Certain drugs may cause vitiligo, so patients should be monitored.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Certain physical traits can lead to health issues and need ongoing management.

Certain skin and family history markers predict vitiligo severity and treatment needs.

Cancer survivors need better skin care to improve their quality of life.

Keratinocyte stem cells are crucial for skin renewal and have potential in wound healing and tissue regeneration.